Why the study?
The study was conducted to identify potential serum biomarkers for insulin resistance in patients with polycystic ovary syndrome.
Are there differentially expressed serum proteins that can serve as biomarkers for insulin resistance in patients with PCOS?
Population
218 PCOS patients aged 18 to 35 years
Comparison
PCOS with insulin resistance vs PCOS without insulin resistance
Authors
Loading...
APOC3 association with HOMA-IR in PCOS is hypothesis-generating; leaves open biomarker validation in prospective studies before any clinical use.
Are there differentially expressed serum proteins that can serve as biomarkers for insulin resistance in patients with PCOS?
APOC3 is a potential diagnostic serum biomarker for insulin resistance in patients with polycystic ovary syndrome.
Li et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: